Has crizotinib significantly impacted non-small-cell lung cancer therapy?

Expert Opin Pharmacother. 2020 Nov;21(16):1927-1930. doi: 10.1080/14656566.2020.1796971. Epub 2020 Jul 27.

Authors

Emanuele Vita^{1

2}, Alessio Stefani^{1

2}, Ettore D'Argento^{1

2}, Giampaolo Tortora^{1

2}, Emilio Bria^{1

2}

Affiliations

¹ Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS , Roma, Italy.
² Medical Oncology, Università Cattolica del Sacro Cuore , Roma, Italy.

PMID: 32717154
DOI: 10.1080/14656566.2020.1796971

No abstract available

Keywords: ALK fusion; NSCLC; ROS1 fusion; crizotinib; met aberration.

Publication types

Editorial
Research Support, Non-U.S. Gov't